呼吸道合胞病毒及其感染相关TLRs的研究进展

doi:10.3976/j.issn.1002-4026.2020.01.007

Abstract

Abstract: Respiratory syncytial virus (RSV) is the leading cause of respiratory tract infections in infants. Toll-like receptors, one of the pattern recognition receptors involved in innate immunity, play an important role in the identification and eradication of RSVs. However, this is not adequately examined, which has limited the development of antiviral drugs and vaccines. In this study, we reviewed the studies on the immunologic process of RSV-related Toll-like receptors in recent years and described the shortcomings of the methods and tendencies of the current studies. This is intended to provide ideas and methods for the further studies on new anti-RSV drugs and their mechanisms.

Key words: respiratory syncytial virus, toll-like receptors, mechanism, anti-virus

CLC Number:

R289

DU Hai-tao, SUN Tie-feng, WANG Ping, AN Feng-tian, HU Ya-nan, LI Na. Advances in respiratory syncytial virus and its infection-related Toll-like receptors[J].Shandong Science, 2020, 33(1): 42-50.

References 55

1	YOU D H, SARAVIA J, SIEFKER D, et al. Crawling with virus:translational insights from a neonatal mouse model on the pathogenesis of respiratory syncytial virus in infants [J]. Journal of Virology, 2016, 90(1): 2-4. doi: 10.1128/jvi.01026-15
2	SCHMIDT H, DAS A, NAM H, et al. Epidemiology and outcomes of hospitalized adults with respiratory syncytial virus: a 6-year retrospective study[J]. Influenza and Other Respiratory Viruses, 2019, 13(4): 331-338. doi: 10.1111/irv.12643
3	NAIR H, NOKES D J, GESSNER B D, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis[J]. The Lancet, 2010, 375(9725): 1545-1555. doi: 10.1016/S0140-6736(10)60206-1
4	CARIO E, PODOLSKY D K. Differential alteration in intestinal epithelial cell of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease[J]. Infection and Immunity, 2000, 68(12): 7010-7017. doi: 10.1128/iai.68.12.7010-7017.2000
5	谢晓虹. 呼吸道合胞病毒感染后气道上皮细胞株Toll样受体表达及其功能研究[D]. 重庆: 重庆医科大学, 2009.
6	刘娟娟, 张婷, 米芋枚. 呼吸道合胞病毒感染对气道上皮细胞表皮生长因子受体、紧密连接相关蛋白及黏蛋白表达的影响[J]. 中国当代儿科杂志, 2019, 21(3): 294-299. doi: 10.7499/j.issn.1008-8830.2019.03.020
7	BAWAGE S S, TIWARI P M, PILLAI S, et al. Recent advances in diagnosis, prevention, and treatment of human respiratory syncytial virus[J]. Advances in Virology, 2013, 2013: 1-26. doi: 10.1155/2013/595768
8	SUN Y, KIM EJ, FELT SA, et al. A specific sequence in the genome of respiratory syncytial virus regulates the generation of copy-back defective viral genomes［J］. PLoS Pathogens，2019,15(4): e1007707. doi: 10.1371/journal.ppat.1007707
9	MASTRANGELO P, HEGELE R. RSV fusion: time for a new model[J]. Viruses, 2013, 5(3): 873-885. doi: 10.3390/v5030873
10	BOYINGTON J C, JOYCE M G, SASTRYM, et al. Structure-based design of head-only fusion glycoprotein immunogens for respiratory syncytial virus[J]. PLoS One, 2016, 11(7): e0159709. doi: 10.1371/journal.pone.0159709
11	WIEGAND M A, GORI-SAVELLINI G, GANDOLFO C, et al. A respiratory syncytial virus vaccine vectored by a stable chimeric and replication-deficient Sendai virus protects mice without inducing enhanced disease [J]. Journal of Virology, 2017, 91(10): e02298. doi: 10.1128/jvi.02298-16
12	RALLABHANDI P, PHILLIPS R L, BOUKHVALOVA M S, et al. Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2[J]. mBio, 2012, 3(4): e00218. doi: 10.1128/mbio.00218-12
13	ARAUJO G C, SILVA R H T, SCOTT L P B, et al. Structure and functional dynamics characterization of the ion channel of the human respiratory syncytial virus (hRSV) small hydrophobic protein (SH) transmembrane domain by combining molecular dynamics with excited normal modes[J]. Journal of Molecular Modeling, 2016, 22(12): 286. doi: 10.1007/s00894-016-3150-6
14	TAWAR R G, DUQUERROY S, VONRHEIN C, et al. Crystal structure of a nucleocapsid-like nucleoprotein-RNA complex of respiratory syncytial virus[J]. Science, 2009, 326(5957): 1279-1283. doi: 10.1126/science.1177634
15	BARIK S. Respiratory syncytial virus mechanisms to interfere with type 1 interferons[M]//Current Topics in Microbiology and Immunology. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013: 173-191. doi: 10.1007/978-3-642-38919-1_9
16	LO M S, BRAZAS R M, HOLTZMAN M J. Respiratory syncytial virus nonstructural proteins NS1 and NS2 mediate inhibition of Stat2 and alpha/beta interferon responsiveness[J]. Journal of Virology, 2005, 79(14): 9315-9319. doi: 10.1128/jvi.79.14.9315-9319.2005
17	BOSSERT B, MAROZIN S, CONZELMANN K K. Nonstructural proteins NS1 and NS2 of bovine respiratory syncytial virus block activation of interferon regulatory factor 3[J]. Journal of Virology, 2003, 77(16): 8661-8668. doi: 10.1128/jvi.77.16.8661-8668.2003
18	汪旻旻, 孙涛, 袁晓玲, 等. NS2激活TLR7抑制RSV感染肺泡上皮细胞中IFN的表达[J]. 安徽医科大学学报, 2017, 52(11): 1632-1637. doi: 10.19405/j.cnki.issn1000-1492.2017.11.011
19	SUN Y, L-PEZ C B. The innate immune response to RSV: advances in our understanding of critical viral and host factors[J]. Vaccine, 2017, 35(3): 481-488. doi: 10.1016/j.vaccine.2016.09.030
20	dI GIOIA M, ZANONI I. Toll-like receptor co-receptors as regulators of the immune response[J]. Molecular Immunology, 2015, 63(2): 143-152. doi: 10.1016/j.molimm.2014.05.008
21	CHAN Y K, GACK M U. Viral evasion of intracellular DNA and RNA sensing[J]. Nature Reviews Microbiology, 2016, 14(6): 360-373. doi: 10.1038/nrmicro.2016.45
22	YONEYAMA M, ONOMOTO K, JOGI M, et al. Viral RNA detection by RIG-I-like receptors[J]. Current Opinion in Immunology, 2015, 32: 48-53. doi: 10.1016/j.coi.2014.12.012
23	WANG S, ZHENG G, ZHAO L, et al. Shp-2 contributes to anti-RSV activity in human pulmonary alveolar epithelial cells by interfering with the IFN-α-induced Jak/Stat1 pathway[J]. Journal of Cellular and Molecular Medicine,2015,19(10):2432-40. doi: 10.1111/jcmm.12629
24	SEGOVIA J, SABBAH A, MGBEMENA V, et al. TLR2/MyD88/NF-κB pathway, reactive oxygen species, potassium efflux activates NLRP3/ASC inflammasome during respiratory syncytial virus infection[J]. PLoS One, 2012, 7(1): e29695. doi: 10.1371/journal.pone.0029695
25	MURAWSKI M R, BOWEN G N, CERNY A M, et al. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2[J]. Journal of Virology, 2009,83(3):1492-1500. doi: 10.1128/JVI.00671-08
26	YANG F, LI X, YANG Y, et al. A polysaccharide isolated from the fruits of Physalis alkekengi L. induces RAW264.7 macrophages activation via TLR2 and TLR4-mediated MAPK and NF-κB signaling pathways［J］. International Journal of Biological Macromolecules,2019,140:895-906. doi: 10.1016/j.ijbiomac.2019.08.174
27	ASANKA SANJEEWA K K, JAYAWARDENA T U, Kim H S, et al. Fucoidan isolated from Padina commersonii inhibit LPS-induced inflammation in macrophages blocking TLR/NF-κB signal pathway［J］. Carbohydrate Polymers,2019,224:115195. doi: 10.1016/j.carbpol.2019.115195
28	崔振泽,徐超,迟磊.基于“肺肠理论”和胆汁酸代谢网络探讨定喘汤对呼吸道合胞病毒感染大鼠肠道菌群调节的研究[J].中国中西医结合儿科学,2018,10(06):461-465. doi: 10.13288/j.11-2166 /r.2019.11.007
29	CYR S L, ANGERS I, GUILLOT L, et al. TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model[J]. Vaccine, 2009, 27(3): 421-430. doi: 10.1016/j.vaccine.2008.10.073
30	李萌, 戴启刚, 汪受传, 等. 金欣口服液对呼吸道合包病毒感染RAW264.7细胞及BALB/c小鼠TLRs负性调控因子A20表达的影响[J]. 中华中医药杂志, 2014, 29(8): 2480-2483.
31	黄艳娴. rhIFN-α1b对RSV感染鼠肺病变及JAK/STAT和TLR4/NF-κB信号通路的影响[D]. 西安: 第四军医大学, 2015.
32	李涛. 金欣口服液对RSV活化诱导的TLR4信号转导通路的作用机制研究[D]. 南京: 南京中医药大学, 2014.
33	YUAN X L, HU T, HE H W, et al. Respiratory syncytial virus prolifically infects N2a neuronal cells, leading to TLR4 and nucleolin protein modulations and RSV F protein co-localization with TLR4 and nucleolin[J]. Journal of Biomedical Science, 2018, 25: 13. doi: 10.1186/s12929-018-0416-6
34	ZHU H, FU Z, GAO L, et al. Genetic polymorphisms of toll-like receptor 4 are associated with respiratory syncytial virus infection in a Chinese infant population[J]. Clinical Laboratory, 2015, 61(10): 1391-1399. doi: 10.7754/clin.lab.2015.150145
35	汪茂荣, 朱进, 张怡青, 等. 抗人Toll样受体4单克隆抗体的制备及其生物活性研究[J]. 免疫学杂志, 2011, 27(7): 599-602. doi: 10.13431/j.cnki.immunol.j.20110141
36	何汉文. TLR3、TLR7受体在呼吸道合胞病毒感染A549细胞诱导Ⅰ型干扰素中的作用研究[D]. 合肥: 安徽医科大学, 2015.
37	SONG S, LEE J J, KIM H J, et al. Fas-associated factor 1 negatively regulates the antiviral immune response by inhibiting translocation of interferon regulatory factor 3 to the nucleus[J]. Molecular and Cellular Biology, 2016,36(7):1136-1151. doi: 10.1128/MCB.00744-15
38	GUINN ZiP. Interferon regulatory factor 3 plays a role in macrophage responses to interferon-γ［J］. Immunobiology,2019,224:565-574. doi: 10.1016/j.imbio.2019.04.004
39	WANG G, KOUWAKI T, MUGIKURA K,et al. Cytoplasmic dsRNA induces the of and mRNAs in differentiated human cells［EB/OL］.［2019-05-12］.http://dx.doi.org/10.1074/jbc.RA119.009783. doi: 10.1074/jbc.RA119.009783
40	KO R,PARK H, LEE N,et al.Glycogen synthase kinase3 β regulates antiviral responses of TLR3 via TRAF2-Src Axis［J］.J Immunol, 2019,203(11):2990-2999. doi: 10.4049/jimmunol.1900685
41	LIM H K,HUANG S X L,CHEN J,et al.Severeinfluenza pneumonitis in children with inherited TLR3 deficiency［J］.The Journal of Experimental Medicine,2019,216:2038-2056. doi: 10.1084/jem.20181621
42	何汉文, 王葱, 杜博易, 等. TLR7在呼吸道合胞病毒感染A549细胞诱导Ⅰ型干扰素中的作用[J]. 安徽医科大学学报, 2015,50(11): 1560-1565. doi: 10.19405/j.cnki.issn1000-1492.2015.11.007
43	HOSAKOTE Y M, JANTZI P D, ESHAM D L, et al. Viral-mediated inhibition of antioxidant enzymes contributes to the pathogenesis of severe respiratory syncytial virus bronchiolitis[J]. American Journal of Respiratory and Critical Care Medicine, 2011, 183(11): 1550-1560. doi: 10.1164/rccm.201010-1755oc
44	CASTRO S M, GUERRERO-PLATA A, SUAREZ-REAL G, et al. Antioxidant treatment ameliorates respiratory syncytial virus–induced disease and lung inflammation[J]. American Journal of Respiratory and Critical Care Medicine, 2006, 174(12): 1361-1369. doi: 10.1164/rccm.200603-319oc
45	朱童娜, 吴璇, 邱欢, 等. 呼吸道合胞病毒感染人肺上皮细胞诱导氧化应激对TLR7基因及其下游因子表达的影响[J]. 安徽医科大学学报, 2014,49(11): 1539-1543. doi: 10.19405/j.cnki.issn1000-1492.2014.11.004
46	SUN T, YU H Y, ZHANG C L, et al. Respiratory syncytial virus infection up-regulates TLR7 by inducing oxidative stress via the Nrf2/ARE pathway in A549 cells[J]. Archives of Virology, 2018, 163(5): 1209-1217. doi: 10.1007/s00705-018-3739-4
47	韩欢, 古今刚, 吴文文, 等. 11744例儿童7项呼吸道病毒抗原检测结果[J]. 武汉大学学报(医学版), 2019, 40(3): 425-428. doi: 10.14188/j.1671-8852.2018.1276
48	杜海涛,孙铁锋,王平, 等. 清热药抗呼吸道合胞病毒的研究进展[J].中成药,2019,41(10):2435-2441. doi: 10. 3969 /j.issn.1001-1528. 2019. 10. 031
49	黄燕, 徐超, 崔振泽, 等. 定喘汤对呼吸道合胞病毒感染大鼠体内免疫网络平衡因子的影响研究[J]. 中医儿科杂志, 2018, 14(2): 10-15. doi: 10.16840/j.issn1673-4297.2018.02.03
50	覃黎葵, 张奉学, 黄笑娟, 等. 银翘散对呼吸道合胞病毒感染小鼠呼吸系统的作用研究[J]. 新中医, 2018, 50(5): 24-30. doi: 10.13457/j.cnki.jncm.2018.05.006
51	徐建亚, 彭璐璐, 汪受传, 等. 金欣口服液对RSV感染细胞TLR4及TNF-α表达的影响[J]. 南京中医药大学学报, 2012, 28(6): 544-547. doi: 10.14148/j.issn.1672-0482.2012.06.017
52	杜江. 金银花主要成分绿原酸对RSV感染RAW264.7细胞的TLR3信号通路的影响[J]. 齐齐哈尔医学院学报, 2017, 38(6): 626-628. doi: 10.3969/j.issn.1002-1256.2017.06.003
53	云云, 汪长中, 桂丽, 等. 黄芩苷经由TLR4信号转导通路抗呼吸道合胞病毒作用的研究[J]. 中成药, 2013, 35(6): 1116-1121. doi: 10.3969/j.issn.1001-1528.2013.06.002
54	谢秀春. 金欣口服液对干扰TLR4表达后RSV诱导的TRIF/NFκB调控作用[D]. 南京: 南京中医药大学, 2014.
55	范奕熳, 袁斌, 周立华, 等. 清肺口服液对呼吸道合胞病毒感染小鼠IL-2和IL-10水平的影响[J]. 中华中医药杂志, 2017, 32(8): 3696-3699.

[1]	LIU Shuang, DONG Hongjing, CHEN Panpan, WANG Xiao. Research progress on the mechanisms by which natural phenolic compounds alleviate hyperuricemia [J]. Shandong Science, 2024, 37(2): 12-19.
[2]	LUO Yaqin, HUANG Wei. Progress in the research on the mechanism of action of Scutellaria baicalensis and its active ingredients in treating ulcerative colitis [J]. Shandong Science, 2024, 37(2): 20-28.
[3]	LIU Kechun, WANG Yongcheng, ZANG Xiaohan, XIA Qing, ZHANG Yun, ZHANG Shanshan, SUN Chen. Advancements in network pharmacology and zebrafish modeling for studying traditional Chinese medicine’s effective substances and mechanisms of action [J]. Shandong Science, 2024, 37(2): 29-35.
[4]	FU Zhaoju, CHENG Guo, LIN Dengmei, LI Jun, ZHANG Nannan. Experimental study and network pharmacological analysis of the anti-inflammatory action mechanism of Mahonia bealei (Fort.) Carr. [J]. Shandong Science, 2024, 37(1): 24-31.
[5]	ZHANG Hanxiao, LIU Yuran, LIU Yuan, NIU Zichen. A multitask learning model for the prediction of short-term subway passenger flow [J]. Shandong Science, 2024, 37(1): 95-106.
[6]	HE Zhenbo, ZHANG Li, GAO Mingxin, LUAN Lingyu. Research progress of green scale inhibitors for circulating cooling water [J]. Shandong Science, 2023, 36(5): 102-120.
[7]	WEN Yuya, DONG Ting, JIANG Zhangsheng, CHEN Jie, TIAN Liwei, ZHAO Chenling, TANG Lulu. The mechanism of Gandouling tablet in alleviating hepatolenticular degeneration neuroinflammation via the regulation of the TLR4/NF-κB/NLRP3 signaling pathway [J]. Shandong Science, 2023, 36(4): 42-51.
[8]	YIN Zhipeng, GAO Yunyun, LIU Wenwen, GUO Pengbo, ZHAO Yinghui. Exploring the mechanism of Xiangsha Liujunzi Decoction in treating Helicobacter pylori-associated gastritis based on network pharmacology and molecular docking technology [J]. Shandong Science, 2023, 36(4): 52-60.
[9]	SUN Tiefeng, DONG Limin, JIAO Ziqi, WANG Ping. Exploration of the dosing pattern and anti-respiratory syncytial virus mechanism of traditional Chinese medicine based on data mining and network pharmacology [J]. Shandong Science, 2023, 36(3): 1-9.
[10]	ZHU Jie, WANG Zheng, LIANG Yanni. The mechanism of Xiaoqinglong Decoction in treatment of COVID-19 based on network pharmacology [J]. Shandong Science, 2023, 36(3): 10-17.
[11]	ZHAO Xin, HUANG Biyun, WU Dan, ZHANG Mei. The mechanism of Guishaozhenxian Tablet in the treatment of temporal lobe epilepsy based on network pharmacology and molecular docking [J]. Shandong Science, 2023, 36(3): 27-37.
[12]	ZHUANG Hao, LI Yang, TAO Mingkun. CNN-LSTM driver intention recognition method based on Attention mechanism [J]. Shandong Science, 2023, 36(2): 103-111.
[13]	LIU Wenwen, LI Changgeng, KONG Na, LIU Shuang, DONG Hongjing. Study on the mechanism of Shiweiyipi Granules based on network pharmacology and molecular docking [J]. Shandong Science, 2023, 36(2): 33-40.
[14]	LI Yan, LI Ziwen, LI Limin, WANG Mengxia, ZHANG Peng, WU Zhengzhi. Exploring the mechanism of Mori Cortex in the treatment of type 2 diabetes mellitus based on network pharmacology [J]. Shandong Science, 2023, 36(1): 41-50.
[15]	PENG Peng, JIA Shun-ping. Diversion parking guidance strategy of shared bicycles under reward mechanism considering user preference [J]. Shandong Science, 2022, 35(6): 123-130.

Advances in respiratory syncytial virus and its infection-related Toll-like receptors

PDF (PC)

Like

Knowledge

Abstract

Cite this article

share this article

References 55

Related Articles 15

Metrics

Comments

Recommended 0